Latest Financials News

Dotz Nano Limited reported a reduced half-year loss and significant progress in its Direct Air Capture technology, while navigating funding uncertainties with key investors.

AdNeo Limited reported a 14% rise in FY25 revenue driven by acquisitions, yet posted a $5.25 million net loss impacted by non-recurring items. Post-year-end capital raising and cost cuts position the company for growth.

Oldfields Holdings Limited reported a reduced net loss of $3.6 million for FY2025, improving from $7.3 million the previous year, despite ongoing working capital constraints and a costly product recall. The company is actively pursuing capital investment to replenish inventory and support recovery.

Synertec Corporation reported an 8% revenue decline in FY25 but achieved a 15% improvement in normalised EBITDA, driven by a strong second-half rebound in Engineering and a 90% surge in Powerhouse revenue.

4DS Memory Limited posted a $9.68 million loss for FY2025 as it advanced its 20nm ReRAM technology, encountering manufacturing setbacks that prompted a detailed root cause analysis. The company secured $8 million in capital to support ongoing development and strategic partnerships.

AIMS Property Securities Fund (APW) reported a remarkable financial year ending June 2025, with net income and revenue more than doubling and net tangible assets per unit rising 31.8%. The fund’s conservative, debt-free approach and diversified portfolio helped it outperform the broader market despite ongoing distribution suspensions.

BauMart Holdings Limited has dramatically reduced its net loss to $123,086 for the year ended June 2025, down from $4.68 million the previous year, as it advances strategic initiatives and strengthens its financial position through a rights issue.

Yojee Limited reported a 34% revenue decline to $675k and a 29% reduction in net loss to $6.02 million for FY2025, reflecting a strategic pivot and accelerated development of its MOSAIC freight forwarding platform. The company raised $8.9 million to fund growth and platform commercialization.

Argent BioPharma reported a net loss of A$17.84 million for FY2025, reflecting a strategic pivot towards core drug development and clinical advancement. The company secured key EU approvals and raised significant capital to support its neuro-immune modulatory pipeline.

Peppermint Innovation Limited reported a modest 4% revenue increase for FY25 alongside a 56% wider net loss, driven by rapid user growth and strategic divestments. The company’s operational momentum contrasts with auditor concerns over its financial sustainability.

Singular Health Group reported a $6.38 million loss for FY2025 while securing a pivotal $1.3 million commercial agreement with US-based Provider Network Solutions to deploy its 3DICOM software. The company also completed a major cloud migration of its platform, positioning itself for growth in the US healthcare market.

Wellnex Life reported a strong 40.4% revenue increase to $23.6 million in FY25, alongside a 57% improvement in normalised EBITDA loss, signaling progress despite ongoing investment costs.